Exploiting neurotrophic factors for the treatment of neurodegenerative conditions: An Australian perspective

Drug Development Research

Volumn 46, Issue 3-4, 1999, Pages 268-276

  Hughes, Richard A ^a   O'Leary, Paul D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antisense; Drug design; Glycosaminoglycans; Nerve growth factors; Oligonucleotides; Peptides

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; LEUKOCYTE MIGRATION INHIBITION FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; XALIPRODEN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CELL SURVIVAL; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; DRUG TARGETING; HUMAN; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NONHUMAN;

EID: 0033000875     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199903/04)46:3/4<268::AID-DDR12>3.0.CO;2-G     Document Type: Article

References (87)

1. Aebischer P, Schluep M, Deglon N, Joseph J-M, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC, Regli R, Baetge EE. 1996. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med 2:696-699.
2. Arakawa Y, Sendtner M, Thoenen H. 1990. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J Neurosci 10:3507-3515.
3. Austin L, Burgess AW. 1991. Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines. J Neurol Sci 101:193-197.
4. Austin L, Bower J, Kurek J, Vakakis N. 1992. Effects of murine leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J Neurol Sci 112:185-191.
5. Baird A. 1994. Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors. Curr Opin Neurobiol 4:78-86.
6. Barbacid M. 1994. The trk family of neurotrophin receptors. J Neurobiol 25:1386-1403.
7. Barrett GL, Bartlett PF. 1994. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci USA 91:6501-6505.
8. Barrett GL, Georgiou A. 1996. The low-affinity nerve growth factor receptor p75NGFR mediates death of PC12 cells after nerve growth factor withdrawal. J Neurosci Res 45:117-128.
9. Bazan JF. 1991. Neuropoietic cytokines in the hematopoietic fold. Neuron 7:197-208.
10. Beglova N, LeSauteur L, Ekiel I, Saragovi HU, Gehring K. 1998. Solution structure and internal motion of a bioactive peptide derived from nerve growth factor. J Biol Chem 273:23652-23658.
11. Braisted AC, Wells JA. 1996. Minimizing a binding domain from protein A. Proc Natl Acad Sci USA 93:5688-5692.
12. Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE. 1998a. Structural modifications of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 272:4350-4359.
13. Brickman YG, Nurcombe V, Ford MD, Gallagher JT, Bartlett PF, Turnbull JE. 1998b. Structural comparison of fibroblast growth factor-specific heparan sulfates from a growing or diffrentiating neuroepithelial cell line. Glycobiology 8:463-471.
14. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhäuser N, Böhm-Matthaei R, Baeuerle PA, Barde Y-A. 1996. Selective activation of NF-KB by nerve growth factor through the neurotrophin receptor p75. Science 272:542-545.
15. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716-719.
16. Chao MV. 1994. The p75 neurotrophin receptor. J Neurobiol 25:1373-1385.
17. Chao M, Casaccia-Bonnefil P, Carter B, Chittka A, Kong H, Yoon SO. 1998. Neurotrophin receptors: mediators of life and death. Brain Res Rev 26:295-301.
18. Chapman BS. 1995. A region of the 75 kDa neurotrophin receptor homologous to the death domains of TNFR-1 and Fas. FEBS Lett 374:216-220.
19. Cheema SS, Richards LJ, Murphy M, Bartlett P. 1994a. Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglia of neonatal rat. J Neurosci Res 37:213-218.
20. Cheema SS, Richards LJ, Murphy M, Bartlett PF. 1994b. Leukemia inhibitory factor rescues motoneurones from axotomy-induced cell death. NeuroReport 5:989-992.
21. Cheema SS, Barrett GL, Bartlett PF. 1996. Reducing p75 nerve growth factor receptor levels using antisense oligonucleotides prevents the loss of axotomized sensory neurons in the dorsal root ganglia of newborn rats. J Neurosci Res 46:239-245.
22. Chiu AY, Chen EW, Loera S. 1993. A motor neuron-specific epitope and the low-affinity nerve growth factor receptor display reciprocal patterns of expression during development, axotomy and regeneration. J Comp Neurol 328:351-363.
23. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM, Schatz PJ, Baccanari DP, Wrighton NC, Barrett RW, Dower WJ. 1997. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 276:1696-1699.
24. Davis S, Aldrich TH, Valenzuela DM, Wong V, Furth ME, Squinto SP, Yancopoulos GD. 1991. The receptor for ciliary neurotrophic factor. Science 253:59-63.
25. Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD. 1993. LIFRβ and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260:1805-1808.
26. Dittrich F, Thoenen H, Sendtner M. 1994. Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol 35:151-163.
27. Ernfors P, Lindefors N, Chan-Palay V, Persson H. 1990. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer's type. Dementia 1:138-145.
28. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC. 1996. Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116-1120.
29. Fantl WJ, Johnson DE, Williams LT. 1993. Signaling by receptor tyrosine kinases. Ann Rev Biochem 62:453-481.
30. Finklestein DI, Bartlett PF, Horne MK, Cheema SS. 1996. Leukemia inhibitory factor is a myotrophic and neurotrophic agent that enhances reinnervation of muscle in the rat. J Neurosci Res 46: 122-128.
31. Frade JM, Barde Y-A. 1998. Nerve growth factor: two receptors, multiple functions. BioEssays 20:137-145.
32. Frade JF, Rodríguez-Tébar A, Barde YA. 1996. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383:166-168.
33. Giménez y Ribotta M, Revah F, Pradier L, Loquet I, Mallet J, Privat A. 1997. Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res 48:281-285.
34. Götz R, Koster R, Winkler C, Raulf F, Loftspeich F, Schartl M, Thoenen H. 1994. Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372:266-269.
35. Granholm AC, Albeck D, Backman C, Curtis M, Ebendal T, Friden P, Henry M, Hoffer B, Kordower J, Rose GM, Soderstrom S, Bartus RT. 1998. A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review. Rev Neurosci 9:31-55.
36. Hantzopoulos PA, Suri C, Glass DJ, Goldfarb MP, Yancopoulos GD. 1994. The low affinity NGF receptor, p75, can collaborate with each of the trks to potentiate functional responses to the neurotrophins. Neuron 13:187-201.
37. Hefti F. 1994. Neurotrophic factor therapy for nervous system degenerative diseases. J Neurobiol 25:1418-1435.
38. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. 1991. High affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor. Nature 350:678-683.
39. Hilton DJ. 1992. LIF: lots of interesting functions. Trends Biochem Sci 17:72-76.
40. Hughes RA, Sendtner M, Goldfarb M, Lindholm D, Thoenen H. 1993a. Evidence that fibroblast growth factor 5 (FGF-5) is a major muscle-derived survival factor for cultured spinal motoneurons. Neuron 10:369-377.
41. Hughes RA, Sendtner M, Thoenen H. 1993b. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 36:663-671.
42. Ikeda K, Klindosz B, Greene T, Cedarbaum JM, Wong V, Lindsay RM, Mitsumoto H. 1995. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 37:505-511.
43. Johnson DE, Williams LT. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41.
44. Joseph SJ, Ford MD, Barth C, Portbury S, Bartlett PF, Nurcombe V, Greferath U. 1996. A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variat, Development 122:3443-3452.
45. Kaplan DR, Miller FD. 1997. Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 9:213-221.
46. Kaplan DR, Stephens RM. 1994. Neurotrophin signal transduction by the trk receptor. J Neurobiol 25:1404-1417.
47. Lander AD. 1994. Targeting the glycosaminoglycan-binding sites on proteins. Chem Biol 1:73-78.
48. LeSauteur L, Wei L, Gibbs BF, Saragovi HU. 1995. Small peptide mimics of nerve growth factor bind trkA receptors and affect biological responses. J Biol Chem 270:6564-6569.
49. Lewin GR, Mendell LM. 1993. Nerve growth factor and nociception. Trends Neurosci 16:353-359.
50. Lindberg M, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA. 1998. Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol 18:3357-3367.
51. Lindsay RM. 1994. Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol Aging 15:249-251.
52. Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA. 1996. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 Å. Science 273:464-471.
53. Lohof AM, Ip NY, Poo M-M. 1993. Fotentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 363:350-353.
54. Longo FM, Manthorpe M, Xie YM, Varon S. 1997. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J Neurosci Res 48:1-17.
55. Martinou J-C, Martinou I, Kato AC. 1992. Cholinergic differentiation factor (CDF/LIF) promotes the survival of isolated rat embryonic motoneurons in vitro. Neuron 8:737-744.
56. Mason IJ. 1994. The ins and outs of fibroblast growth factors. Cell 78:547-552.
57. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. 1993. Disruption of the CNTF gene results in motor neuron degeneration. Nature 365:27-32.
58. McKeehan WL, Wang F, Kan M. 1998. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucl Acid Res Mol Biol 59:135-176.
59. Murphy M, Reid K, Hilton DJ, Bartlett PF. 1991. Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc Natl Acad Sci USA 88:3498-3501.
60. Nurcombe V, Ford MD, Wildschut JA, Bartlett PF. 1993. Developmental regulation of neural response to FGF-1 and FGF-2 heparan sulfate proteoglycan. Science 260:103-106.
61. Ohbayashi N, Hoshikawa M, Kimura S, Yamasaki M, Fukui S, Itoh N. 1998. Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18. J Biol Chem 273:18161-18164.
62. O'Leary PD, Hughes RA. 1998. Structure-activity relationships of conformationally constrained peptide analogues ofloop 2 of brain-derived neurotrophic factor. J Neurochem 70:1712-1721.
63. Oppenheim RW. 1991. Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501.
64. Oppenheim RW, Prevette D, Fuller F. 1992. The lack of effect of basic and acidic fibroblast growth factors on the naturally occurring death of neurons in the chick embryo. J Neurosci 12:2726-2734.
65. Patterson PH, Nawa H. 1993. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell/Neuron 72/10:123-137.
66. Penn RD, Kroin JS, York MM, Cedarbaum JM. 1997. Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery 40:94-100.
67. Pradines A, Magazin M, Schilz P, Le Fur G, Caput D, Ferrara P. 1995. Evidence for nerve growth factor-potentiating activities of the non-peptidic compound SR 57746A in PC12 cells. J Neurochem 64:1954-1964.
68. Rabizadeh S, Oh J, Zhong L-t, Yang J, Bitler CM, Butcher LL, Bredesen DE. 1993. Induction of apoptosis by the low affinity NGF receptor. Science 261:345-348.
69. Richards LJ, Kilpatrick TJ, Dutton R, Tan S-S, Gearing DP, Bartlett PF, Murphy M. 1996. Leukaemia inhibitory factor or related factors promote the differentiation of neuronal and astrocytic precursors within the developing murine spinal cord. Eur J Neurosci 8:291-299.
70. Robinson RC, Grey LM, Staunton D, Vankelecom H, Vernallis AB, Moreau J-F, Stuart DI, Heath JK, Jones EY. 1994. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell 77:1101-1116.
71. Rodríguez-Tébar A, Dechant G, Barde Y-A. 1990. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 4:487-492.
72. Rodríguez-Tébar A, Dechant G, Götz R, Barde Y-A. 1992. Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J 11:917-922.
73. Sendtner M, Carroll P, Holtmann B, Hughes RA, Thoenen H. 1994a. Ciliary neurotrophic factor. J Neurobiol 25:1436-1453.
74. Sendtner M, Dittrich F, Hughes RA, Thoenen H. 1994b. Actions of CNTF and neurotrophins on degenerating motoneurons: preclinical studies and clinical implications. J Neurol Sci 123(suppl):77-84.
75. Snyder SH, Sabatini DM, Lai MM, Steiner JP, Hamilton GS, Suzdak PD. 1998. Neural actions of immunophilin ligands. Trends Pharmacol Sci 19:21-26.
76. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 59:99-106.
77. Stahl N, Yancopoulos GD. 1993. The alphas, betas and kinases of cytokine receptor complexes. Cell 74:587-590.
78. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, Ihle JN, Yancopoulos GD. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science 263:92-95.
79. Tatasaki W, Kajino Y, Kajino K, Murali R, Greene MI. 1997. Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNFα binding to its receptor. Nat Biotech 15:1266-1270.
80. Tham S, Dowsing B, Finklestein D, Donato R, Cheema SS, Bartlett PF, Morrison WA. 1997. Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res 47:208-215.
81. Thoenen H. 1991. The changing scene of neurotrophic factors. Trends Neurosci 15:165-170.
82. Thoenen H, Hughes RA, Sendtner M. 1993. Trophic support of motoneurons: physiological, pathophysiological and therapeutic implications. Exp Neurol 124:47-55.
83. Tian S-S, Lamb P, King AG, Miller SG, Kessler L, Luengo JI, Averill L, Johnson RK, Gleason JG, Pelus LM, Dillon SB, Rosen J. 1998. A small, non-peptidyl mimic of granulocyte-colony-stimulating factor. Science 281:257-259.
84. Van der Zee CEEM, Ross GM, Riopelle BJ, Hagg T. 1996. Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice. Science 274:1729-1732.
85. von Bartheld CS, Kinoshita Y, Prevette D, Yin Q-W, Oppenheim RW, Bothwell M. 1994. Positive and negative effects of neurotrophins on the isthmo-optic nucleus in chick embryos. Neuron 12:639-654.
86. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ. 1996. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-463.
87. Yamamori T, Fukuda K, Aebersold R, Korsching S, Fann MJ, Patterson PH. 1989. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246:1412-1416.